Dermatologic Manifestations of Mixed Connective Tissue Disease Treatment & Management

Updated: Jun 06, 2017
  • Author: Robert A Schwartz, MD, MPH; Chief Editor: William D James, MD  more...
  • Print
Treatment

Medical Care

Medical care for mixed connective-tissue disease (MCTD) must be individualized and based on the severity and type of organ involvement. Plasmapheresis may be a successful treatment because of the removal of immune complexes in serum and improvement of visceral circulation. [35]

Next:

Consultations

Because of different presenting symptoms associated with mixed connective-tissue disease (MCTD), consultation with the following specialists should be considered:

  • A dermatologist should evaluate the skin lesions.
  • An internal medicine specialist should evaluate organ involvement.
Previous
Next:

Activity

Mixed connective-tissue disease (MCTD) patients have restricted mobility if joint and muscle pain is significant.

Previous
Next:

Complications

Approximately 10% of patients with mixed connective-tissue disease (MCTD) have an increased risk of cancer development during the course of disease. Many affected patients receive immunosuppressive therapy, which may put them at increased risk of nontuberculous mycobacterial and other infections. [36, 37]

Previous
Next:

Prevention

Deterrence and prevention of mixed connective-tissue disease (MCTD) includes photoprotection.

Previous